Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06669585

Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 3

Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 3 (COBRA)

Status
Recruiting
Phase
Study type
Observational
Enrollment
64 (estimated)
Sponsor
L. Cinnamon Bidwell · Academic / Other
Sex
All
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of two different strains of cannabis flower one day and while not intoxicated another day. Event-related potentials (ERPs) are measured via electroencephalogram (EEG) during the recognition memory task. Blood is collected to quantify THC and CBD exposure. Participants also complete self-report measures of medical history, sleep quality, subjective cognitive function, physical activity, psychological functioning, substance use, and acute drug effects.

Detailed description

Previous research has established cannabis's harmful cognitive impact, with particularly robust and consistent effects in the domain of episodic memory. However, prior work has not sufficiently considered that the memory effects of cannabis are the compound action of different cannabinoids, which vary in their pharmacology and effects. Specifically, CBD, a non-psychotomimetic component of cannabis (doesn't produce a "high"), is thought to have cognitively protective properties and may mitigate some of the harmful effects of THC. Further, few prior studies have tested the effects of high potency strains that are commonly available. This study tests the effects of commercially available cannabis flower strains on recognition memory performance and ERPs that are related to different underlying memory processes in healthy, regular cannabis users. An episodic memory task is used to assess recognition memory, which asks participants to discriminate between previously studied and non-studied items using pictures as stimuli. Participants complete the same memory task while intoxicated one day and not intoxicated another day. A THC-dominant strain and a strain containing both THC and CBD are included in the study. Participants self-administer one of the two cannabis strains prior to memory encoding and retrieval. Blood is collected to determine THC and CBD exposure, as well as to explore how genetic variation in genes related to cannabinoid metabolism, cannabis-related behavior, and neurocognitive function associate with memory function before and after cannabis use. Participants also complete self-report measures of medical history, sleep quality, subjective cognitive function, physical activity, psychological functioning, substance use, and acute drug effects.

Conditions

Interventions

TypeNameDescription
DRUGCannabis (smoked flower)Self-Directed Use (ad-libitum)

Timeline

Start date
2024-10-09
Primary completion
2026-01-01
Completion
2026-01-01
First posted
2024-11-01
Last updated
2024-12-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06669585. Inclusion in this directory is not an endorsement.